Closure Medical Stockholders Approve Acquisition Agreement With Johnson & Johnson

Closure Medical Stockholders Approve Acquisition Agreement With
Johnson & Johnson 


RALEIGH, N.C., June 2  /PRNewswire-FirstCall/ -- Closure Medical Corporation
(NASDAQ:CLSR) today announced that at a special meeting held today in Raleigh,
North Carolina, its stockholders approved the agreement pursuant to which
Johnson & Johnson will acquire Closure Medical for $27.00 per share. The
proposed transaction, which was announced on March 4, 2005, is expected to
close tomorrow, June 3, 2005, subject to the satisfaction of the remaining
closing conditions.

About Closure Medical Corporation

Closure Medical Corporation is a global leader in the development and
manufacture of innovative biomaterial-based medical devices that fulfill the
needs of healthcare practitioners, patients and consumers. For additional
information on Closure Medical visit its website at http://www.closuremed.com/.

This release includes forward-looking statements that are based on assumptions
about many important factors, including the satisfaction of the conditions to
closing; general industry and market conditions; general domestic and
international economic conditions, such as interest rate and currency exchange
rate fluctuations; technological advances and patents attained by competitors;
challenges inherent in new product development, including obtaining regulatory
approvals; and the factors listed in Closure Medical's most recent Annual
Report on Form 10-K. As such, they involve risks that could cause actual
results to differ materially. Closure Medical does not undertake to update its
forward-looking statements. 

DATASOURCE: Closure Medical Corporation



CONTACT:  Joe Allen (investors), [phone], ; or

Len Hall (media), [phone], , both of Allen & Caron

Inc; or Benny Ward, CFO of CLOSURE Medical Corp, [phone]   



Web site:  http://www.closuremed.com/ 

Copyright